Abstract
A NUMBER of workers have determined the plasma salicylate-levels in man at various time intervals after oral doses of aspirin, while others have studied salicylate excretion1–3. However, there appear to be few reports of the concurrent determination of plasma and urine salicylate after dosage with aspirin. In this laboratory, the plasma salicylate concentrations and the urinary salicylate excretion-rates have been studied simultaneously in two groups of eight men who received a single oral dose of either aspirin B.P. or aloxiprin. (The latter is the Approved Name selected by the British Pharmacopœia Commission to describe a “polymeric condensation product of aluminium oxide and aspirin”).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harrison, J. W. E., Packman, E. W., and Abbott, D. D., J. Amer. Pharm. Assoc., 48, 50 (1959).
Truitt, E. B., and Morgan, Ann M., Arch. Intern. Pharmacodyn., 135, 105 (1962).
Levy, G., J. Pharm. Sci., 50, 388 (1961).
Cummings, A. J., Martin, B. K., and Wiggins, L. F., J. Pharm. Pharmacol. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CUMMINGS, A., MARTIN, B. Relationship of Plasma Salicylate Concentration to Urinary Salicylate Excretion-Rate. Nature 195, 1104–1105 (1962). https://doi.org/10.1038/1951104a0
Issue date:
DOI: https://doi.org/10.1038/1951104a0